Speaking following the announcement today (Tuesday 5 June 2007) that the Scottish Executive plans to increase the purchase age of cigarettes from 16-18, Dr Andrew Buist, Deputy Chairman of the BMA’s Scottish GP committee, said:
Learning and physical disabilities and behavioural problems are part of fetal alcohol spectrum disorders [FASD]. These lifelong conditions can drastically impact on the lives of the individual and those around them.
The synthetic form of a hormone previously found to produce a feeling of fullness when eating and reduce body weight, also may help curb binge eating and the desire to eat high-fat foods and sweets.
Andrew Speaker learned Monday evening that his third consecutive sputum smear test had come back negative. This confirmed results from several smear tests previously performed at other institutions.
US HHS Secretary Mike Leavitt announced that HHS has awarded a contract for $500 million to Bavarian Nordic A/S of Copenhagen, Denmark to manufacture and deliver 20 million doses of a next generation modified vaccinia Ankara (MVA) smallpox vaccine.
A close cousin of the bacterium that debilitated thousands of World War I soldiers has been isolated at UCSF from a patient who had been on an international vacation. The woman, who has since recovered, suffered from symptoms similar to malaria or typhoid fever, two infections that can occur in returning travelers.
AIDS Healthcare Foundation (AHF), the US? largest provider of HIV/AIDS healthcare, education and prevention and operator of free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, today praised Merck for its decision to offer to reduce the price of its antiretroviral drug, efavirenz (marketed outside the US under the brand name Strocrin), in Thailand, but chided the multinational drug company for making the price cut offer contingent upon the Government of Thailand revoking a compulsory license it had issued in November 2006 for the manufacture and/or importation of a generic version of the drug.
On June 5, 2007, the New England Journal of Medicine published results of an interim analysis of the cardiovascular safety trial of rosiglitazone (brand name, Avandia).
The research, by QBI neuroscientist Professor Jason Mattingley and colleagues at the University of Melbourne and University College London, has implications for understanding “spatial neglect”, a disorder associated with damage to the brain’s parietal lobe ? an area that plays an important role in integrating sensory information from various parts of the body, and in planning eye- and limb-movements.
As stem cells in the blood grow older, genetic mutations accumulate that could be at the root of blood diseases that strike people as they age, according to work done in mice by researchers at the Stanford University School of Medicine.